174 related articles for article (PubMed ID: 37573859)
1. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.
Kyle SD; Siriwardena AN; Espie CA; Yang Y; Petrou S; Ogburn E; Begum N; Maurer LF; Robinson B; Gardner C; Lee V; Armstrong S; Pattinson J; Mort S; Temple E; Harris V; Yu LM; Bower P; Aveyard P
Lancet; 2023 Sep; 402(10406):975-987. PubMed ID: 37573859
[TBL] [Abstract][Full Text] [Related]
2. Primary care treatment of insomnia: study protocol for a pragmatic, multicentre, randomised controlled trial comparing nurse-delivered sleep restriction therapy to sleep hygiene (the HABIT trial).
Kyle SD; Madigan C; Begum N; Abel L; Armstrong S; Aveyard P; Bower P; Ogburn E; Siriwardena A; Yu LM; Espie CA
BMJ Open; 2020 Mar; 10(3):e036248. PubMed ID: 32139496
[TBL] [Abstract][Full Text] [Related]
3. A targeted psychological treatment for sleep problems in young people at ultra-high risk of psychosis in England (SleepWell): a parallel group, single-blind, randomised controlled feasibility trial.
Waite F; Černis E; Kabir T; Iredale E; Johns L; Maughan D; Diamond R; Seddon R; Williams N; Yu LM; Freeman D;
Lancet Psychiatry; 2023 Sep; 10(9):706-718. PubMed ID: 37562423
[TBL] [Abstract][Full Text] [Related]
4. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
5. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
6. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
7. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
8. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
[TBL] [Abstract][Full Text] [Related]
9. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
[TBL] [Abstract][Full Text] [Related]
10. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: follow-up of the CoBalT randomised controlled trial.
Wiles NJ; Thomas L; Turner N; Garfield K; Kounali D; Campbell J; Kessler D; Kuyken W; Lewis G; Morrison J; Williams C; Peters TJ; Hollinghurst S
Lancet Psychiatry; 2016 Feb; 3(2):137-44. PubMed ID: 26777773
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial.
Freeman D; Waite F; Startup H; Myers E; Lister R; McInerney J; Harvey AG; Geddes J; Zaiwalla Z; Luengo-Fernandez R; Foster R; Clifton L; Yu LM
Lancet Psychiatry; 2015 Nov; 2(11):975-83. PubMed ID: 26363701
[TBL] [Abstract][Full Text] [Related]
13. Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial.
Vedaa Ø; Kallestad H; Scott J; Smith ORF; Pallesen S; Morken G; Langsrud K; Gehrman P; Thorndike FP; Ritterband LM; Harvey AG; Stiles T; Sivertsen B
Lancet Digit Health; 2020 Aug; 2(8):e397-e406. PubMed ID: 33328044
[TBL] [Abstract][Full Text] [Related]
14. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of i-Sleep, a guided online CBT intervention, for patients with insomnia in general practice: protocol of a pragmatic randomized controlled trial.
van der Zweerde T; Lancee J; Slottje P; Bosmans J; Van Someren E; Reynolds C; Cuijpers P; van Straten A
BMC Psychiatry; 2016 Apr; 16():85. PubMed ID: 27038786
[TBL] [Abstract][Full Text] [Related]
16. Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
Marsden J; Kelleher M; Gilvarry E; Mitcheson L; Bisla J; Cape A; Cowden F; Day E; Dewhurst J; Evans R; Hardy W; Hearn A; Kelly J; Lowry N; McCusker M; Murphy C; Murray R; Myton T; Quarshie S; Vanderwaal R; Wareham A; Hughes D; Hoare Z
EClinicalMedicine; 2023 Dec; 66():102311. PubMed ID: 38045803
[TBL] [Abstract][Full Text] [Related]
17. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
[TBL] [Abstract][Full Text] [Related]
18. Group-delivered cognitive behavioural therapy versus waiting list in the treatment of insomnia in primary care: study protocol for a pragmatic, multicentre randomized controlled trial.
Hrozanova M; Meisingset I; Kallestad H; Pallesen S; Nordstoga AL; Skarpsno ES
BMC Prim Care; 2023 Mar; 24(1):61. PubMed ID: 36864376
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
[TBL] [Abstract][Full Text] [Related]
20. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
